David Eansor
2019
In 2019, David Eansor earned a total compensation of $2.3M as Senior Vice President Biotechnology at Bio-Techne, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $613,448 |
|---|---|
| Option Awards | $900,053 |
| Salary | $501,380 |
| Stock Awards | $299,907 |
| Other | $8,250 |
| Total | $2,323,038 |
Eansor received $900.1K in option awards, accounting for 39% of the total pay in 2019.
Eansor also received $613.4K in non-equity incentive plan, $501.4K in salary, $299.9K in stock awards and $8.3K in other compensation.
Rankings
In 2019, David Eansor's compensation ranked 5,196th out of 13,971 executives tracked by ExecPay. In other words, Eansor earned more than 62.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,196 out of 13,971 | 63rd |
Division Manufacturing | 1,936 out of 5,701 | 66th |
Major group Chemicals And Allied Products | 680 out of 2,200 | 69th |
Industry group Drugs | 571 out of 1,886 | 70th |
Industry Biological Products, Except Diagnostic Substances | 129 out of 389 | 67th |
Source: SEC filing on September 9, 2019.
Eansor's colleagues
We found four more compensation records of executives who worked with David Eansor at Bio-Techne in 2019.